Myovant Sciences Stock Debt To Equity
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
Myovant Sciences fundamentals help investors to digest information that contributes to Myovant Sciences' financial success or failures. It also enables traders to predict the movement of Myovant Stock. The fundamental analysis module provides a way to measure Myovant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Myovant Sciences stock.
Myovant |
Myovant Sciences Company Debt To Equity Analysis
Myovant Sciences' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Myovant Sciences Debt To Equity | 138.60 % |
Most of Myovant Sciences' fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myovant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Myovant Sciences has a Debt To Equity of 138%. This is 158.87% higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The debt to equity for all United States stocks is 184.6% lower than that of the firm.
Myovant Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myovant Sciences' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Myovant Sciences could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics of similar companies.Myovant Sciences is currently under evaluation in debt to equity category among its peers.
Myovant Fundamentals
| Return On Asset | -0.18 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (0.39) % | |||
| Current Valuation | 2.6 B | |||
| Shares Outstanding | 97.26 M | |||
| Shares Owned By Insiders | 48.61 % | |||
| Shares Owned By Institutions | 56.21 % | |||
| Number Of Shares Shorted | 8.39 M | |||
| Price To Earning | (8.56) X | |||
| Price To Book | 70.01 X | |||
| Price To Sales | 7.80 X | |||
| Revenue | 230.97 M | |||
| Gross Profit | 72.02 M | |||
| EBITDA | (183.89 M) | |||
| Net Income | (205.98 M) | |||
| Cash And Equivalents | 371.29 M | |||
| Cash Per Share | 3.84 X | |||
| Total Debt | 358.7 M | |||
| Debt To Equity | 138.60 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | (5.75) X | |||
| Cash Flow From Operations | (268.56 M) | |||
| Short Ratio | 11.21 X | |||
| Earnings Per Share | (1.92) X | |||
| Target Price | 27.0 | |||
| Number Of Employees | 579 | |||
| Beta | 2.15 | |||
| Market Capitalization | 2.62 B | |||
| Total Asset | 520.01 M | |||
| Retained Earnings | (811.83 M) | |||
| Working Capital | 123.03 M | |||
| Current Asset | 150.17 M | |||
| Current Liabilities | 27.14 M | |||
| Z Score | 2.8 | |||
| Net Asset | 520.01 M |
About Myovant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myovant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myovant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myovant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |